Related Experiment Video
Updated: Aug 15, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease
S Tsubata1, F Ichida, Y Hamamichi
1Department of Pediatrics, Toyama Medical and Pharmaceutical University, Toyama City, Japan.
Abstract:
Thrombolytic therapy using tissue-type plasminogen activator was performed in a 7-month-old boy with massive mural thrombi in large coronary aneurysms due to Kawasaki disease. Magnetic resonance imaging successfully demonstrated mural thrombi in both proximal and distal coronary aneurysms and their disappearance after thrombolytic therapy. We conclude that for preventing acute myocardial infarction and sudden death intravenous and intracoronary thrombolytic therapy with tissue-type plasminogen activator may help in infants and children with Kawasaki disease who have thrombi in coronary aneurysms.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

